Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
38.85
+0.30 (0.78%)
At close: Apr 13, 2026, 4:00 PM EDT
38.50
-0.35 (-0.90%)
After-hours: Apr 13, 2026, 7:51 PM EDT
Liquidia Market Cap
Liquidia has a market cap or net worth of $3.42 billion as of April 13, 2026. Its market cap has increased by 169.89% in one year.
Market Cap
3.42B
Enterprise Value
3.43B
1-Year Change
169.89%
Ranking
Category
Stock Price
$38.85
Market Cap Chart
Since July 26, 2018, Liquidia's market cap has increased from $167.77M to $3.42B, an increase of 1,940.39%. That is a compound annual growth rate of 47.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 3.40B | 13.21% |
| Dec 31, 2025 | 3.00B | 201.46% |
| Dec 31, 2024 | 995.33M | 20.97% |
| Dec 29, 2023 | 822.82M | 100.28% |
| Dec 30, 2022 | 410.83M | 62.30% |
| Dec 31, 2021 | 253.13M | 98.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkermes | 5.55B |
| Lantheus Holdings | 5.24B |
| Hims & Hers Health | 4.43B |
| Amneal Pharmaceuticals | 4.00B |
| Kiniksa Pharmaceuticals International, | 3.60B |
| Supernus Pharmaceuticals | 2.92B |
| Prestige Consumer Healthcare | 2.68B |
| HUTCHMED (China) | 2.55B |